Family Health & Help Center | |
109 S Jefferson Street Rockville IN 47872-1717 | |
(765) 569-4008 | |
(765) 569-1917 |
Full Name | Family Health & Help Center |
---|---|
Speciality | Family Medicine |
Location | 109 S Jefferson Street, Rockville, Indiana |
Authorized Official Name and Position | Bonnie S Waymire (EXECUTIVE DIRECTOR) |
Authorized Official Contact | 7655695537 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Family Health & Help Center 109 S Jefferson Street Rockville IN 47872-1717 Ph: (765) 569-4008 | Family Health & Help Center 109 S Jefferson Street Rockville IN 47872-1717 Ph: (765) 569-4008 |
NPI Number | 1245392539 |
---|---|
Provider Enumeration Date | 12/14/2006 |
Last Update Date | 04/24/2013 |
Medicare PECOS PAC ID | 4183675473 |
---|---|
Medicare Enrollment ID | O20050203000544 |
News Archive
News outlets report on aspects of the health law designed to foster and test innovation in the nation's health care delivery system.
In an International Journal of Geriatric Psychiatry study of individuals diagnosed with dementia in the United Kingdom, people from minority ethnic backgrounds (Asian and Black patients) had lower cognitive scores and were younger when they were diagnosed with dementia than White patients.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
› Verified 3 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1245392539 | NPI | - | NPPES |
20063300 | Medicaid | IN | |
20063300A | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | (Indiana) | Primary |
Provider Name | John C Linson |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1538226253 PECOS PAC ID: 2567634876 Enrollment ID: I20111011000106 |
News Archive
News outlets report on aspects of the health law designed to foster and test innovation in the nation's health care delivery system.
In an International Journal of Geriatric Psychiatry study of individuals diagnosed with dementia in the United Kingdom, people from minority ethnic backgrounds (Asian and Black patients) had lower cognitive scores and were younger when they were diagnosed with dementia than White patients.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
› Verified 3 days ago
Provider Name | Alexandrea M Warren |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1619300753 PECOS PAC ID: 0840427126 Enrollment ID: I20131211001701 |
News Archive
News outlets report on aspects of the health law designed to foster and test innovation in the nation's health care delivery system.
In an International Journal of Geriatric Psychiatry study of individuals diagnosed with dementia in the United Kingdom, people from minority ethnic backgrounds (Asian and Black patients) had lower cognitive scores and were younger when they were diagnosed with dementia than White patients.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
› Verified 3 days ago
Provider Name | Mary Elizabeth Ulrich |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1588755078 PECOS PAC ID: 9032431028 Enrollment ID: I20141202001222 |
News Archive
News outlets report on aspects of the health law designed to foster and test innovation in the nation's health care delivery system.
In an International Journal of Geriatric Psychiatry study of individuals diagnosed with dementia in the United Kingdom, people from minority ethnic backgrounds (Asian and Black patients) had lower cognitive scores and were younger when they were diagnosed with dementia than White patients.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
› Verified 3 days ago
Provider Name | Crystal J Woods |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1801102579 PECOS PAC ID: 0143455246 Enrollment ID: I20150116000808 |
News Archive
News outlets report on aspects of the health law designed to foster and test innovation in the nation's health care delivery system.
In an International Journal of Geriatric Psychiatry study of individuals diagnosed with dementia in the United Kingdom, people from minority ethnic backgrounds (Asian and Black patients) had lower cognitive scores and were younger when they were diagnosed with dementia than White patients.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
› Verified 3 days ago
Provider Name | Chastity R Frederick |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1780244970 PECOS PAC ID: 9931437159 Enrollment ID: I20190827001284 |
News Archive
News outlets report on aspects of the health law designed to foster and test innovation in the nation's health care delivery system.
In an International Journal of Geriatric Psychiatry study of individuals diagnosed with dementia in the United Kingdom, people from minority ethnic backgrounds (Asian and Black patients) had lower cognitive scores and were younger when they were diagnosed with dementia than White patients.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
› Verified 3 days ago
News Archive
News outlets report on aspects of the health law designed to foster and test innovation in the nation's health care delivery system.
In an International Journal of Geriatric Psychiatry study of individuals diagnosed with dementia in the United Kingdom, people from minority ethnic backgrounds (Asian and Black patients) had lower cognitive scores and were younger when they were diagnosed with dementia than White patients.
Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
Researchers from The University of Texas Medical Branch at Galveston have found that while the 30-day readmission rate for patients with chronic obstructive pulmonary disease has decreased, the mortality rate has increased.
› Verified 3 days ago
Vpchc-rockville Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 727 N. Lincoln Rd, Rockville, IN 47872 Phone: 765-569-1123 Fax: 765-569-6412 | |
Rockville Town Square Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 W High St, Rockville, IN 47872 Phone: 765-569-2057 Fax: 765-569-2340 | |
Parke Clinic, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 503 Anderson St, Rockville, IN 47872 Phone: 765-569-3182 | |
Union Hospital, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 727 No. Lincoln Rd, Union Hospital Inc. D/b/a Rockville Family Medicine, Rockville, IN 47872 Phone: 765-569-1123 Fax: 765-569-6412 | |
Rockville Town Square Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 111 W High St, Rockville, IN 47872 Phone: 765-569-2057 Fax: 765-569-2340 | |
Parke Clinic, Psc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 503 Anderson St, Rockville, IN 47872 Phone: 765-569-3182 Fax: 765-569-2950 |